Abstract: An image processing/displaying apparatus comprises a data storage unit configured to store 3-dimensional volume data, a cross section information generation unit configured to generate cross section information by reconstructing the 3-dimensional volume data stored in the data storage unit, an image display unit configured to display a cross section image of a subject in accordance with the cross section information generated by the cross section information generation unit, a locking unit configured to designate an affected part in the cross section image as a rotation center and a control unit configured to control image rotation on the image display unit so that the affected part is contained in the cross section image, when operation for rotating cross section is performed by an operator.

Abstract: A method for treatment of neuronal disorders and traumatic brain injury is provided which involves timely administration to a subject in need thereof of an effective amount of nefiracetam.

Abstract: A method for treatment of neuronal disorders and traumatic brain injury is provided which involves timely administration to a subject in need thereof of an effective amount of nefiracetam.

Abstract: A method for treatment of neuronal disorders and traumatic brain injury is provided which involves timely administration to a subject in need thereof of an effective amount of nefiracetam.

Abstract: A medicament comprising as an active ingredient a compound represented by the following formula: R2—CH2CONH—R1 wherein R1 represents pyridyl group, a substituted pyridyl group, phenyl group, or a substituted phenyl group; and R2 represents a 2-oxo-1-phyrrolidinyl group which may be substituted (e.g., N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide), which is useful for preventive and/or therapeutic treatment of amnesia caused by, for example, an anesthetic agent for intravenous administration such as propofol.

Abstract: A medicament which comprises as an active ingredient a compound represented by the following formula: R.sup.2 -CH.sub.2 CONH-R.sup.1 wherein R.sup.1 represents a pyridyl group, a substituted pyridyl group, phenyl group, or a substituted phenyl group; and R.sup.2 represents 2-oxo-1-pyrrolidinyl group which may optionally be substituted, and inhibits the development of dependency induced by a narcotic analgesic and/or inhibit the development of tolerance to analgesic action induced by a narcotic analgesic agent.

Abstract: The present invention aims at providing a drug which is highly effective in improving decline of mental functions such as disorientation, which are the major symptoms of dementia such as Alzheimer type dementia or cerebrovascular dementia, as well as general side symptoms such as decreased spontaneity, contact disturbances, motivation, emotional disturbances, abnormal behaviors and disturbances in activity of daily living. The agent for improving dementia of the present invention comprises N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide or a salt thereof as an active ingredient.